©istock.com/Andrea Obzerova
Interdisciplinary CompetenceMolecular Diagnostics
Know how in the analysis of genetic material.
For the benefit of patients.

IllnessPrenatally abnormal kidneys / urinary tract, differential diagnosis

Summary

Short information

Comprehensive differential diagnostic panel for Prenatally abnormal kidneys / urinary tract containing 35 expert opinion-curated genes and altogether 106 curated genes according to the clinical signs

ID
PP0015
Number of genes
67 Accredited laboratory test
Examined sequence length
21,9 kb (Core-/Core-canditate-Genes)
224,2 kb (Extended panel: incl. additional genes)
Analysis Duration
on request
Test material
  • Amniotic fluid (after amnocentesis)
  • Chorionic villus
  • Umbilical cord blood
Diagnostic indications

NGS +

[Sanger]

 

Gene panel

Selected genes

NameExon Length (bp)OMIM-GReferenz-Seq.Heredity
HNF1B1674NM_000458.4AD
NPHP33993NM_153240.5AR
PKHD112225NM_138694.4AR
RPGRIP1L3948NM_015272.5AR
ACE3921NM_000789.4AR
ACTG21131NM_001615.4AD
ANOS12043NM_000216.4XLR
BMP41227NM_001202.6AD
BNC23297NM_017637.6AD
CHD78994NM_017780.4AD
CHRNA31518NM_000743.5AR
CRB23858NM_173689.7AR
DHCR71428NM_001360.3AR
DSTYK2790NM_015375.3AD
EYA11779NM_000503.6AD
FANCB2580NM_001018113.3XLR
FGF20636NM_019851.3AR
FOXC21506NM_005251.3AD
FRAS112039NM_025074.7AR
FREM16540NM_144966.7AR
FREM29510NM_207361.6AR
GATA31335NM_001002295.2AD
GLI34743NM_000168.6AD
GPC31743NM_004484.4XLR
GRIP13231NM_021150.4AR
HOXA131167NM_000522.5AD
HPSE21605NM_001166244.1AR
ITGA83192NM_003638.3AR
JAG13657NM_000214.3AD
KDM6A4206NM_021140.4XL
KMT2D16614NM_003482.4AD
KYNU924NM_001032998.2AR
LIFR3294NM_002310.6AD
LMOD11806NM_012134.3AR
LRIG23198NM_014813.3AR
LRP45718NM_002334.4AR
MYH115919NM_002474.3AR
MYL9522NM_006097.5AR
MYLK5745NM_053025.4AR
MYOCD2961NM_001146312.3AD, AR
NIPBL8415NM_133433.4AD
NR0B11413NM_000475.5XL
NRIP13477NM_003489.4AD
PAX21254NM_003987.5AD
PBX11293NM_002585.4AD
REN1221NM_000537.4AR, AD
RET3345NM_020975.6AD, AR
ROBO24185NM_001128929.3AD
ROR22832NM_004560.4AD, AR
RRM2B1272NM_015713.5AR
SALL13975NM_002968.3AD
SALL43162NM_020436.5AD
SAMD94770NM_001193307.2AD
SIX1855NM_005982.4AD
SIX52220NM_175875.5AD
SLC12A13300NM_000338.3AR
SOX171245NM_022454.4AD
STRA62004NM_001142617.2AR
TBC1D13480NM_001253912.2AD
TBX181824NM_001080508.3AD
TFAP2A1296NM_001032280.3AD
TRAP12115NM_016292.3AR
VIPAS391482NM_022067.4AR
VPS33B1854NM_018668.5AR
WNT41056NM_030761.5AD, AR
WNT5A1143NM_003392.7AD
ZIC31404NM_003413.4XLR

Informations about the disease

Clinical Comment

Congenital abnormalities of kidneys + urinary tract are the most common sonographically identified malformations prenatally. Obstructive uropathies account for the majority of cases. The aim of prenatal diagnosis + management is to detect those anomalies having impact on prognosis of the affected child, requiring early postnatal evaluation/treatment to minimize adverse outcomes.

 

Synonyms
  • Alias: Congenital Anomalies of the Kidney and Urinary Tract - CAKUT
  • Alias: Prenatally unusual ultrasound findings in urinary tract
  • Alias: Renal or urinary tract malformation
  • Allelic: Bone marrow failure [panelapp] (EXOC3L)
  • Allelic: Branchiootic syndrome 3 (SIX1)
  • Allelic: Dandy-Walker malformation [panelapp] (EXOC3L)
  • Allelic: Deafness, AD 23 (SIX1)
  • Allelic: Deafness, AD 80 (GREB1L)
  • Allelic: Diabetes mellitus, noninsulin-dependent (HNF1B)
  • Allelic: Diarrhea 10, protein-losing enteropathy type (PLVAP)
  • Allelic: Hydroxykynureninuria (KYNU)
  • Allelic: Hypertension, essential, susceptibility to (AGT)
  • Allelic: Hyperuricemic nephropathy, familial juvenile 2 (REN)
  • Allelic: Manitoba oculotrichoanal syndrome (FREM1)
  • Allelic: Nephronophthisis 3 (NPHP3)
  • Allelic: Renal cell carcinoma (HNF1B)
  • Allelic: Retinitis pigmentosa 23 (OFD1)
  • Allelic: Spermatogenic failure 72 (WDR19)
  • Allelic:Preeclampsia, susceptibility to (AGT)
  • 46XY sex reversal 2, dosage-sensitive (NR0B1)
  • Adrenal hypoplasia, congenital (NR0B1)
  • Alagille syndrome 1 (JAG1)
  • Alagille syndrome 2 (NOTCH2)
  • Arthrogryposis, renal dysfunction, + cholestasis 1 (VPS33B)
  • Bardet-Biedl syndrome 1 (BBS1)
  • Bardet-Biedl syndrome 1, modifier of (ARL6)
  • Bardet-Biedl syndrome 1, modifier of (CCDC28B)
  • Bardet-Biedl syndrome 10 (BBS10)
  • Bardet-Biedl syndrome 11 (TRIM32)
  • Bardet-Biedl syndrome 12 (BBS12)
  • Bardet-Biedl syndrome 13 (MKS1)
  • Bardet-Biedl syndrome 14 (CEP290)
  • Bardet-Biedl syndrome 14, modifier of (TMEM67)
  • Bardet-Biedl syndrome 15 (WDPCP)
  • Bardet-Biedl syndrome 16 (SDCCAG8)
  • Bardet-Biedl syndrome 17 (LZTFL1)
  • Bardet-Biedl syndrome 18 (BBIP1)
  • Bardet-Biedl syndrome 19 (IFT27)
  • Bardet-Biedl syndrome 2 (BBS2)
  • Bardet-Biedl syndrome 20 (IFT172)
  • Bardet-Biedl syndrome 21 (CFAP418)
  • Bardet-Biedl syndrome 22 (IFT74)
  • Bardet-Biedl syndrome 3 (ARL6)
  • Bardet-Biedl syndrome 4 (BBS4)
  • Bardet-Biedl syndrome 5 (BBS5)
  • Bardet-Biedl syndrome 6 (MKKS)
  • Bardet-Biedl syndrome 7 (BBS7)
  • Bardet-Biedl syndrome 8 (TTC8)
  • Bardet-Biedl syndrome 9 (PTHB1)
  • Bartter syndrome, type 1 (SLC12A1)
  • Bifid nose with/-out anorectal + renal anomalies (FREM1)
  • Bladder dysfunction, autonomic, with impaired pupillary reflex + secondary CAKUT (CHRNA3)
  • Branchio-oto-renal syndrome [panelapp] (SIX1)
  • Branchiooculofacial syndrome (TFAP2A)
  • Branchiootorenal syndrome 1, with/-out cataracts (EYA1)
  • Branchiootorenal syndrome 2 (SIX5)
  • CAKUT + VACTERL association [panelapp] (TRAP1)
  • CAKUT [panelapp] (EXOC3L2)
  • CAKUT [panelapp] (PLVAP)
  • CAKUT [panelapp] (SLIT2)
  • CAKUT [panelapp] (TBC1D1)
  • CAKUT syndrome with/-out hearing loss, abnormal ears/developmental delay (PBX1)
  • CHARGE syndrome (CHD7)
  • COACH syndrome 1 (TMEM67)
  • Cenani-Lenz syndactyly syndrome (LRP4)
  • Congenital anomalies of kidney + urinary tract 1 (DSTYK)
  • Congenital anomalies of kidney + urinary tract 2 (TBX18)
  • Congenital anomalies of kidney + urinary tract 3 (NRIP1)
  • Congenital anomalies of kidney + urinary tract with/-out hearing loss, abn. ears/dev. delay (PBX1)
  • Cornelia de Lange syndrome 1 (NIPBL)
  • Cranioectodermal dysplasia 2 (WDR35)
  • Cranioectodermal dysplasia 4 (WDR19)
  • Duane-radial ray/Okihiro/acrorenoocular syndrome (SALL4)
  • Fanconi anemia, complementation group B (FANCB)
  • Focal segmental glomerulosclerosis 9 (CRB2)
  • Fraser syndrome 1 (FRAS1)
  • Fraser syndrome 2 (FREM2)
  • Fraser syndrome 3 (GRIP1)
  • Glomerulosclerosis, focal segmental, 7 (PAX2)
  • Guttmacher syndrome (HOXA13)
  • Hajdu-Cheney syndrome (NOTCH2)
  • Hand-foot-uterus syndrome (HOXA13)
  • Heterotaxy, visceral, 1, XL (ZIC3)
  • Hypogonadotropic hypogonadism 1 with/-out anosmia, Kallmann syndrome 1 (ANOS1)
  • Hypogonadotropic hypogonadism 5 with/-out anosmia (CHD7)
  • Hypoparathyroidism, sensorineural deafness, and renal dysplasia (GATA3)
  • Joubert syndrome 10 (OFD1)
  • Joubert syndrome 2 (TMEM216)
  • Joubert syndrome 28 (MKS1)
  • Joubert syndrome 29 (TMEM107)
  • Joubert syndrome 34 (B9D2)
  • Joubert syndrome 4 (NPHP1)
  • Joubert syndrome 6 (TMEM67)
  • Joubert syndrome 7 (RPGRIP1L)
  • Kabuki syndrome 1 (KMT2D)
  • Kabuki syndrome 2 (KDM6A)
  • Lymphedema-distichiasis syndrome with renal disease + diabetes mellitus (FOXC2)
  • MIRAGE syndrome (SAMD9)
  • Meckel syndrome 1 (MKS1)
  • Meckel syndrome 10 (B9D2)
  • Meckel syndrome 11 (TMEM231)
  • Meckel syndrome 12 (KIF14)
  • Meckel syndrome 13 (TMEM107)
  • Meckel syndrome 14 (TXNDC15)
  • Meckel syndrome 2 (TMEM216)
  • Meckel syndrome 3 (TMEM67)
  • Meckel syndrome 4 (CEP290)
  • Meckel syndrome 5 (RPGRIP1L)
  • Meckel syndrome 6 (CC2D2A)
  • Meckel syndrome 7 (NPHP3)
  • Meckel syndrome 8 (TCTN2)
  • Meckel syndrome 9 (B9D1)
  • Megabladder, congenital (MYOCD)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 1 (MYLK)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 2 (MYH11)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 3 (LMOD1)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 4 (MYL9)
  • Megacystis-microcolon-intestinal hypoperistalsis syndrome 5 (ACTG2)
  • Microcephaly, facial dysmorphism, renal agenesis + ambiguous genitalia syndrome (CTU2)
  • Microphthalmia, syndromic 6 (BMP4)
  • Microphthalmia, syndromic 6 (BNC2)
  • Microphthalmia, syndromic 9 (STRA6)
  • Mitochondrial DNA depletion syndrome 8A, encephalomyopathic type with renal tubulopathy (RRM2B)
  • Mullerian aplasia + hyperandrogenism (WNT4)
  • Multinucleated neurons, anhydramnios, renal dysplasia, cereb. hypoplasia, hydranencephaly (CEP55)
  • Nephronophthisis 1, juvenile (NPHP1)
  • Nephronophthisis 11 (TMEM67)
  • Nephronophthisis 13 (WDR19)
  • Nephronophthisis 2, infantile (INVS)
  • Nephronophthisis 4 (NPHP4)
  • Neurodevelopmental-craniofacial syndrome with variable renal and cardiac abnormalities (ZMYM2)
  • Neurofacioskeletal syndrome with/-out renal agenesis (HS2ST1)
  • Orofaciodigital syndrome I (OFD1)
  • Pallister-Hall syndrome (GLI3)
  • Papillorenal syndrome (PAX2)
  • Polycystic kidney disease 1 (PKD1)
  • Polycystic kidney disease 2 (PKD2)
  • Polycystic kidney disease 3 (GANAB)
  • Polycystic kidney disease 4, with/-out hepatic disease (PKHD1)
  • Prune belly syndrome (CHRM3)
  • RHYNS syndrome (TMEM67)
  • Renal agenesis [panelapp] (RET)
  • Renal cysts + diabetes syndrome (HNF1B)
  • Renal dysplasia [panelapp] (EXOC3L)
  • Renal hypodysplasia/aplasia 1 (ITGA8)
  • Renal hypodysplasia/aplasia 2 (FGF20)
  • Renal hypodysplasia/aplasia 3 (GREB1L)
  • Renal tubular dysgenesis (ACE)
  • Renal tubular dysgenesis (AGTR1)
  • Renal tubular dysgenesis (REN)
  • Renal-hepatic-pancreatic dysplasia 1 (NPHP3)
  • Robinow syndrome, AD 1 (WNT5A)
  • Robinow syndrome, AR (ROR2)
  • SERKAL syndrome (WNT4)
  • Senior-Loken syndrome 1 (NPHP1)
  • Senior-Loken syndrome 3 (SLSN3)
  • Senior-Loken syndrome 4 (NPHP4)
  • Senior-Loken syndrome 5 (IQCB1)
  • Senior-Loken syndrome 6 (CEP290)
  • Senior-Loken syndrome 7 (SDCCAG8)
  • Senior-Loken syndrome 8 (WDR19)
  • Senior-Loken syndrome 9 (TRAF3IP1)
  • Short-rib thoracic dysplasia 5 +/- polydactyly (WDR19)
  • Short-rib thoracic dysplasia 7 +/- polydactyly (WDR35)
  • Simpson-Golabi-Behmel syndrome, type 1 (GPC3)
  • Simpson-Golabi-Behmel syndrome, type 2 (OFD1)
  • Smith-Lemli-Opitz syndrome (DHCR7)
  • Stromme syndrome: intestinal atresia, ocular +/- renal/cardiac abnormalities, microcephaly (CENPF)
  • Structural heart defects + renal anomalies syndrome (TMEM260)
  • Stuve-Wiedemann syndrome/Schwartz-Jampel type 2 syndrome (LIFR)
  • Townes-Brocks branchiootorenal-like syndrome (SALL1)
  • Townes-Brocks syndrome 1 (SALL1)
  • Tubulointerstitial kidney disease, AD, 4 (REN)
  • Urofacial syndrome 1 (HPSE2)
  • Urofacial syndrome 2 (LRIG2)
  • VACTERL association, XL (ZIC3)
  • Ventriculomegaly with cystic kidney disease (CRB2)
  • Vertebral, cardiac, renal + limb defects syndrome 1 (HAAO)
  • Vertebral, cardiac, renal + limb defects syndrome 2 (KYNU)
  • Vertebral, cardiac, renal + limb defects syndrome 3 (NADSYN1)
  • Vertebral, cardiac, tracheoesophageal, renal + limb defects (WBP11)
  • Vesicoureteral reflux 2 (ROBO2)
  • Vesicoureteral reflux 3 (SOX17)
Heredity, heredity patterns etc.
  • AD
  • AR
  • XL
  • XLR
OMIM-Ps
  • Multiple OMIM-Ps
ICD10 Code

Bioinformatics and clinical interpretation

Test-Stärken

  • DAkkS-akkreditiertes Labor
  • EU-Richtlinie für IVD in Umsetzung
  • Qualitäts-kontrolliert arbeitendes Personal
  • Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
  • Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
  • eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
  • unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
  • unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
  • unsere umfassenden klinischen Aussagen

Testeinschränkungen

  • Gene mit eingeschränkter Abdeckung werden gekennzeichnet
  • Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
  • es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
  • die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
  • Gen-Konversionen
  • komplexe Inversionen
  • Balancierte Translokationen
  • Mitochondriale Varianten
  • Repeat-Expansionen, sofern nicht anders dokumentiert
  • nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
  • niedriger Mosaik-Status
  • Repeat-Blöcke von Mononukleotiden
  • Indels >50bp (Insertionen-Deletionen)
  • Deletionen oder Duplikationen einzelner Exons
  • Varianten innerhalb von Pseudogenen
  • die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde

Laboratory requirement

  • Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.

  • Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.

  • Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.

  • Die Untersuchung wird auch für Selbstzahler angeboten.